Patient Recruitment in the Age of Immunotherapy

The persistent challenge of patient recruitment is nothing if not well-documented. It has appeared in countless journals and blogs; it exists across all phases of clinical research. Some of its causes are most common in, or even unique to, Phase I trials. The absence of medical necessity among Phase I healthy volunteers leaves little motivation … Read More →

Snapshot: 2 Challenges in Research Today

The progress of new drugs from clinic to market faces numerous challenges that organizations across the industry work tirelessly to address. As an EDC company, Medrio, for example, strives to eliminate inefficiencies in data management that can hinder clinical trials. In this post, we thought we’d take a sample of some of the other challenges … Read More →

Phase I in the Age of Precision Medicine and Patient Diversity

As clinical research evolves and becomes more refined, the industry is coming to acknowledge a simple truth: that everyone is different. A drug that works wonders for one individual may have little to no effect on, or even be detrimental to, another. Alternatively, the discovery that a treatment is ineffective or dangerous in a small … Read More →

Monthly News Roundup: September 2016

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and … Read More →

3 Rockin’ Recruitment Platforms

Recruitment practices have evolved a great deal, becoming increasingly tech-oriented over the last few years. Here are three recently-developed online tools researchers are using to keep their enrollment levels high.

Letting Clinical Trial Patients Do the Talking

In this era of booming technology, principal investigators of clinical trials have tried all sorts of things to overcome persistent patient recruitment hurdles. Their approaches include study websites, outreach through social media, apps helping willing clinical trial patients find appropriate clinical trials, and more. Enrollment rates, however, remain less than ideal, and recruitment continues to … Read More →

The Anatomy of an Ideal Clinical Trial Patient

A good candidate is interested and altruistic Clinical trials require time and energy of those who enroll. Many are repelled by these requirements. Others, however, have personal interests that make them enthusiastic about participating. Some are passionate about medical science, and enchanted by the opportunity to be on the cutting edge of advancements in disease … Read More →

Coverage Policy: Boosting or Busting Clinical Recruitment?

There are numerous obstacles that stand in the way of patient recruitment for clinical trials. This is neither a secret in the clinical research industry, nor is it difficult to understand. After all, at face value, being the subject of an experiment studying the unknown effects of a controlled substance may not, frankly, sound so … Read More →

Zika, Malaria, and Pregnant Women in Clinical Trials

We recently published a post exploring the need for increased diversity among participants in clinical trials. In that post, we cited certain demographics, including African Americans, the elderly, and more, as some of the most underrepresented in clinical settings. But there is one demographic that we didn’t mention, one whose frequent exclusion from clinical trials … Read More →

The Importance of Diversity in Clinical Trials

In the world of clinical trials, uniformity can be a dirty word. From blind use of placebos to dosage variation, incorporation of variables is an essential part of any study. But it’s important for researchers to ensure variety not just in the drugs being tested, but among patients as well. A lack of diversity can … Read More →